Biocryst Pharmaceuticals (BCRX) Current Taxes (2015 - 2021)

Biocryst Pharmaceuticals has reported Current Taxes for 7 years, with the latest figure at $2.6 million in Q4 2021.

• For the quarter ending Q4 2021, Current Taxes rose 3177.5% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2021 stood at $2.6 million (up 3177.5% YoY), and the FY2021 full-year result was $2.6 million, up 3177.5% from the prior year.
• Current Taxes for Q4 2021 stood at $2.6 million, up from $80000.0 in the prior quarter.
• The five-year high for Current Taxes was $2.6 million in Q4 2021, with the low at $51000.0 in Q4 2018.
• Historically, Current Taxes has averaged $593600.0 across 5 years, with a median of $80000.0 in 2020.
• Annual changes were most pronounced in 2018 — Current Taxes plunged 65.54% — and 2021, when it surged 3177.5%.
• Biocryst Pharmaceuticals' Current Taxes stood at $148000.0 in 2017, then tumbled by 65.54% to $51000.0 in 2018, then soared by 31.37% to $67000.0 in 2019, then rose by 19.4% to $80000.0 in 2020, then surged by 3177.5% to $2.6 million in 2021.
• The last three Current Taxes figures came in at $2.6 million (Q4 2021), $80000.0 (Q4 2020), and $67000.0 (Q4 2019), per Business Quant data.